New release the word is out
The word is out and this is just the beginning. Today was cdn investors next few days investors from the USA
will be comming in.
https://www.stockhouse.com/pfolio.aspx?frame=/pfolio_V2.asp%3F%26portid%3D1301688%26lang%3D
This is from the new release:
"BELLUS Health's most advanced pharmaceutical candidate is KIACTA (eprodisate) to treat Amyloid A (AA) amyloidosis, a disease marked by an abnormal accumulation of certain proteins that can cause organ dysfunction, organ failure, and even death. In December 2010, KIACTA entered a confirmatory Phase III trial funded by Celtic Therapeutics, a global private equity firm.
-- The Company's pharmaceutical pipeline also includes NRM8499, a prodrug for Alzheimer's disease (AD) that entered a Phase I trial in March 2010.
-- Additionally, through a wholly owned subsidiary, OVOS Natural Health Inc., the Company markets a clinically tested nutraceutical called VIVIMIND (tramiprosate/homotaurine) to protect memory function. VIVIMIND is available online and has been granted approval for sale in Canada, Italy, and Spain. "
Incredible potential
Do your dd
SB